DADATA·ANALYSIS
FREE
company · cik 1279704

Cellectar Biosciences, Inc.

CLRBNasdaqSIC 2834public
financials · annual · usd2026
Net income-$21.8M
Total assets$15.0M
Total liabilities$5.1M
Equity$8.5M
Operating cash-$23.1M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts1